Showing results (181-190 of 214) with videos related to

Sort By:
Pageof 22
Journal of Medical Virology|July 15, 2003
Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spotsAli Judd, John Parry, Matthew Hickman, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2014
In vitro and in vivo activities of HPi1, a selective antimicrobial against Helicobacter pyloriEkaterina Gavrish, Binu Shrestha, Chao Chen, et al.
Antimicrobial Agents and Chemotherapy|January 8, 2020
Mechanism-of-Action Classification of Antibiotics by Global Transcriptome ProfilingAubrie O'Rourke, Sinem Beyhan, Yongwook Choi, et al.
Microbiology Spectrum|December 23, 2021
Mutasynthetic Production and Antimicrobial Characterization of Darobactin AnalogsNils Böhringer, Robert Green, Yang Liu, et al.
Plos Computational Biology|March 29, 2021
Predicting antimicrobial mechanism-of-action from transcriptomes: A generalizable explainable artificial intelligence approachJosh L Espinoza, Chris L Dupont, Aubrie O'Rourke, et al.
Cell Reports|September 25, 2012
Role of unusual P loop ejection and autophosphorylation in HipA-mediated persistence and multidrug toleranceMaria A Schumacher, JungKi Min, Todd M Link, et al.
AIDS (London, England)|September 10, 2002
Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, RussiaTim Rhodes, Catherine Lowndes, Ali Judd, et al.
Chemical Science|January 11, 2019
Structural studies suggest aggregation as one of the modes of action for teixobactinCarl Öster, Grzegorz P Walkowiak, Dallas E Hughes, et al.
Mbio|May 16, 2022
A Silent Operon of Photorhabdus luminescens Encodes a Prodrug Mimic of GTPNegar Shahsavari, Boyuan Wang, Yu Imai, et al.
Chemistry & Biology|April 2, 2014
Lassomycin, a ribosomally synthesized cyclic peptide, kills mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2Ekaterina Gavrish, Clarissa S Sit, Shugeng Cao, et al.
Pageof 22